Value of a run-in period in a drug trial during pregnancy
- 31 May 1990
- journal article
- research article
- Published by Elsevier in Controlled Clinical Trials
- Vol. 11 (3), 187-198
- https://doi.org/10.1016/0197-2456(90)90013-r
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- The Studies of Left Ventricular Dysfunction (SOLVD) experience with a placebo run-phase: Jeffrey L. Probstfield, Debra H. Weiner, Shrikant I. Bangdiwala, Linda Cahill, Henry Demots, Marie Galvao, Helena J. Henzlova, James Hill, Michel Joyal, and James B. Young for the SOLVD InvestigatorsControlled Clinical Trials, 1989
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- A randomized trial of aspirin and β-carotene among U.S. physiciansPreventive Medicine, 1985
- The coronary primary prevention trial: Design and implementationJournal of Chronic Diseases, 1979
- Sample sizes for medical trials with special reference to long-term therapyJournal of Chronic Diseases, 1968